In conclusion, even though Trop2 was not detectable in EBV-negative de novo DLBCL, we were able to immunohistochemically detect high Trop2 expression in a total of three samples of EBV-positive DLBCL transformed from AITL. This evidence concerns the gene TACSTD2 and angioimmunoblastic T-cell lymphoma.